Quantum BioPharma Q3 Financial Report: Achieved $572,000 in Revenue through Digital Asset Portfolio

2025-11-08 08:53:05

According to GlobeNewswire, Quantum BioPharma (NASDAQ: QNTM) today announced its financial results for the third quarter of 2025, showing a significant improvement in the company's financial condition, with a 275% quarter-over-quarter increase in shareholder equity, a 50% reduction in total liabilities, and an 87% decrease in the debt-to-equity ratio.

The company's digital asset portfolio (primarily consisting of Bitcoin) has realized a gain of $572,000, with the total value of digital assets increasing from $800,000 at the end of 2024 to the current $5.2 million.

Source

Risk warning

Topic or theme Real-time Trading of Cryptocurrency and Stocks: A Record of Institutional Crypto Holdings and Capital Operations

Recently, stablecoin concept stocks have continued to strengthen, with several listed companies establishing reserves of crypto assets. Stocks of crypto companies are becoming a special "crypto hotspot": traditional market investors are beginning to pay attention to companies in the crypto industry, while those in the crypto circle view the price changes of crypto stocks as one of the indicators of market fluctuations. This topic will continue to focus on the dynamics of related projects, institutional movements, market performance, and the strategic logic behind them, gaining insights into the development path of this wave of integration between crypto and equity.